For patients aged 50 years or older and at 3 years post diagnosis, less frequent mammograms were non-inferior compared with annual mammograms for breast cancer-specific survival, recurrence-free interval, and overall survival, and should be considered for this population.
This ESMO Webinar Series is available to all ESMO Members.
An NDA has been submitted to the FDA seeking the approval of TAR-200 for BCG-unresponsive high-risk NMIBC with CIS, with or without papillary tumors.
There is an urgent need to globally strengthen cancer-care systems considering projections that cancer cases will substantially increase during the coming years, said global leaders…
On Jan 20, 2025, US President Donald Trump issued an executive order to withdraw the USA from WHO. The move could jeopardise public health care…
Acute toxicity following prostate radiotherapy was statistically significantly associated with late toxicity and with decrement in patient-reported QOL metrics. These data support efforts to evaluate…
Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, shares her excitement for the 19th International Symposium on Acute Leukemias (ISALXIX), taking place on March 16-19,…
We summarize results of a pooled analysis from a multicenter, open-label, phase I/II trial published by Cortes et al. evaluating the effectiveness and tolerability of…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
A woman in her 40s presented with a 3-month history of abdominal and pelvic pain, nausea, and vomiting. Ultrasound revealed a 15 cm solid heterogeneous…
The xT CDx assay is now available nationwide in the United States for use in solid tumor profiling.
